361 Capital’s Acadia Healthcare ACHC Stock Holding History

361 Capital’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-29,173	Closed	-$1.19M	–	318
2018 Q2	$1.19M	Buy	+29,173	New	+$1.18M	0.27%	212

Other funds holding ACHC

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

361 Capital's ACHC Position: Q3 2018 in Review

361 Capital sold out of Acadia Healthcare (ACHC) in Q3 2018, closing a stake of 29,173 shares — an estimated $1.19M sold.

361 Capital first reported a position in ACHC in Q2 2018 and held it in 1 quarter. The position peaked at $1.19M in Q2 2018. 253 funds tracked by Wall St. Rank hold ACHC as of Q3 2018.

361 Capital reported no remaining Acadia Healthcare position as of Q3 2018 after selling out during the quarter.
361 Capital sold 29,173 Acadia Healthcare shares in Q3 2018, an estimated $1.19M.
361 Capital first reported a position in Acadia Healthcare in Q2 2018 and held it in 1 quarter.
361 Capital's Acadia Healthcare position peaked at $1.19M in Q2 2018.
253 funds tracked by Wall St. Rank held Acadia Healthcare as of Q3 2018.

Based on 361 Capital's 13F filing for Q3 2018, filed 13 Nov 2018.